Exagen Diagnostics Receives $16,817,541 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1214328f-0aed-4e35-8ec5-93a0192e9d52 - Date
1/26/2016 - Company Name
Exagen Diagnostics - Mailing Address
1261 Liberty Way Vista, CA 92081 USA - Company Description
Exagen Diagnostics Inc. discovers, validates and commercializes small sets of genomic markers, providing prognostic reagents for commercial laboratory testing and for pharmaceutical use in clinical trials. - Website
http://www.exagen.com - Transaction Type
Venture Equity - Transaction Amount
$16,817,541 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 13 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
